Hammer Marilyn J, Eckardt Patricia, Barton-Burke Margaret
College of Nursing, New York University in New York.
Rockefeller University.
Oncol Nurs Forum. 2016 Nov 1;43(6):694-696. doi: 10.1188/16.ONF.694-696.
The primary goal of the thousands of registered trials in cancer research is to extend survival. With evaluation of efficacy, safety, and tolerability, healthcare providers must ensure that the principles described in the Belmont Report are upheld and that patients are truly informed when signing a consent form. In this article, two cases are highlighted, and reasons for participating in clinical trials are discussed. Challenges, such as healthcare literacy, patients' dedication to their healthcare providers, and choosing between multiple trials, are also explored.
癌症研究中数千项注册试验的主要目标是延长生存期。在评估疗效、安全性和耐受性时，医疗保健提供者必须确保坚持《贝尔蒙报告》中所述的原则，并确保患者在签署同意书时得到真正的告知。本文突出了两个案例，并讨论了参与临床试验的原因。还探讨了一些挑战，如医疗保健素养、患者对其医疗保健提供者的忠诚度以及在多个试验之间进行选择等。
